Summary
How cytotoxic T lymphocytes (CTLs) sense T cell receptor (TCR) signaling in order to specialize an area of plasma membrane for granule secretion is not understood. Here, we demonstrate that immune synapse formation led to rapid localized changes in the phosphoinositide composition of the plasma membrane, both reducing phosphoinositide-4-phosphate (PI(4)P), PI(4,5)P2, and PI(3,4,5)P3 and increasing diacylglycerol (DAG) and PI(3,4)P2 within the first 2 min of synapse formation. These changes reduced negative charge across the synapse, triggering the release of electrostatically bound PIP5 kinases that are required to replenish PI(4,5)P2. As PI(4,5)P2 decreased, actin was depleted from the membrane, allowing secretion. Forced localization of PIP5Kβ across the synapse prevented actin depletion, blocking both centrosome docking and secretion. Thus, PIP5Ks act as molecular sensors of TCR activation, controlling actin recruitment across the synapse, ensuring exquisite co-ordination between TCR signaling and CTL secretion.
Keywords: phosphatidylinositol 4-phosphate 5-kinase; PIP5K; secretion; cytotoxic T lymphocytes; CTLs; immunological synapse; primary cilia; phospholipids; phosphoinositides phosphatidylinositol 4,5-biphosphate; PI(4,5)P2
Graphical Abstract
Highlights
-
•
Immune synapse formation triggers rapid changes in the membrane composition and charge
-
•
PIP5K is a molecular sensor of TCR activation and is rapidly depleted at the synapse
-
•
PIP5K distribution controls actin recruitment across the immune synapse
-
•
Membrane specialization controls accessibility for centrosome docking and secretion
Gawden-Bone et al. show that during immune synapse formation, rapid depletion of PIP5K at the synapse triggers subsequent changes in membrane composition and actin dynamics to establish a zone of localized granule secretion.
Introduction
Cytotoxic T lymphocytes (CTLs) provide an important line of defense in the immune system, patrolling the body to seek out and destroy virally infected and cancerous cells. They do so with remarkable precision, leaving healthy cells unharmed as they recognize their targets. This is in large part due to a specific mechanism of polarized secretion directed by the centrosome, which docks at the point of contact on the plasma membrane (Stinchcombe et al., 2015), focusing cytotoxic granules for release at the immunological synapse formed between a CTL and its target (Stinchcombe and Griffiths, 2007, Stinchcombe et al., 2006). Secretion is tightly regulated and recent studies have revealed a critical role for the actin cytoskeleton in controlling both the initiation and termination of secretion (Carisey et al., 2018, Hsu et al., 2016, Ritter et al., 2015, Ritter et al., 2017). However, it remains unclear how CTLs translate T cell receptor (TCR) signaling into rapid changes in the membrane, allowing for the tightly orchestrated secretion of granules during TCR activation.
Early imaging studies revealed that the first contacts between CTL and target occur via many small projections (Kalina and Berke, 1976, Sanderson, 1976, Sanderson and Glauert, 1977, Sanderson and Glauert, 1979) that extend from the front of migrating T cells (Ritter et al., 2015). Strikingly, the initial highly interdigitated interface between CTL and target rapidly flattens upon the initiation of TCR signaling to give an extended area of tight membrane contact as the immunological synapse forms (Jenkins et al., 2014). These findings suggest that changes in the composition of the plasma membrane might underlie this transition in membrane structure and raise the possibility that membrane composition might be important for centrosome docking and granule delivery.
Phosphoinositides and other phospholipids play important roles in protein recruitment, signal transduction, and plasma membrane specialization in cells (Di Paolo and De Camilli, 2006, Trimble and Grinstein, 2015). Phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) is the most abundant phosphoinositide, estimated to comprise ∼2% of the plasma membrane in lymphocytes (Lemmon, 2008, Ross et al., 2016). The relative percentages of different phosphoinositides within the plasma membrane are controlled by a series of kinases and phosphatases (Figure S1A; reviewed in Balla, 2013, Kolay et al., 2016, Ooms et al., 2009, Pirruccello and De Camilli, 2012). Regulating PI(4,5)P2 is particularly important as PI(4,5)P2 binds a variety of actin-regulating proteins and in this way regulates actin dynamics across the plasma membrane (Di Paolo and De Camilli, 2006, Janmey and Lindberg, 2004, Pollard and Borisy, 2003, Raucher et al., 2000, Rohatgi et al., 2000). A number of observations support the idea that there are significant changes in the distribution of phosphoinositides and phospholipids in the plasma membrane as the synapse forms. First, TCR signaling triggers recruitment and activation of phospholipase Cγ1 (PLCγ1), which metabolizes PI(4,5)P2, generating diacylglycerol (DAG) that accumulates on the inner leaflet of the CTL plasma membrane in the synapse, playing an important role in centrosome polarization (Quann et al., 2009, Spitaler et al., 2006). Second, PI(3,4,5)P3 becomes restricted to the periphery of the synapse in T cells (Le Floc’h et al., 2013). Third, in keeping with the role of PI(4,5)P2 in recruitment of F-actin, the depletion of PI(4,5)P2 is accompanied by a loss of F-actin across the synapse prior to centrosome docking and cytolytic granule secretion (Ritter et al., 2015, Ritter et al., 2017).
Centrosome docking at the plasma membrane is unusual in cells but is required for ciliogenesis. Recent reports have shown remarkable similarities between the mechanism of centrosome docking during ciliogenesis and immune synapse formation (Stinchcombe et al., 2015, Tanos et al., 2013). Membrane specialization has been reported in primary cilia, with PI(4,5)P2 and PI(3,4,5)P3 found only at the base of the cilium while PI(4)P is found in the ciliary body (Chávez et al., 2015, Garcia-Gonzalo et al., 2015, Nakatsu, 2015, Phua et al., 2018). This raises the possibility that centrosome docking might be affected by membrane composition.
Our previous studies have revealed that TCR signaling leads to depletion of actin across the synapse, correlating with decreases in PI(4,5)P2 (Ritter et al., 2015). Given the importance of PI(4,5)P2 in both CTL function and ciliogenesis, we decided to examine the phosphoinositide composition as the immunological synapse forms and ask whether membrane specialization is required for centrosome docking and secretion at the immunological synapse. We find that TCR signaling triggers rapid changes in the phosphoinositide composition across the synapse, with cleavage of PI(4,5)P2 to DAG reducing not only actin recruitment but also the negative charge across the synapse. This change in membrane charge prevents phosphatidylinositol 4-phosphate 5-kinases type I (PIP5Ks) from associating with membranes. This in turn prevents replenishment of PI(4,5)P2 at the synapse, maintaining the level of actin depletion required for secretion. Thus, PIP5Ks act as molecular sensors of TCR activation, allowing localized secretion by controlling the membrane composition at the synapse.
Results
PLCγ1 and DAG Accumulate while PI(4,5)P2 and Actin Are Depleted within the First 2 Min after CTLs Contact with Targets
To follow changes in phosphoinositide composition as the immunological synapse forms, we used a panel of live-cell imaging probes capable of distinguishing the plasma membrane pool of phosphoinositides within the PI(4,5)P2 metabolic pathway (Figure S1A), combined with 4D spinning-disc microscopy. In each case we co-expressed the F-actin probe, Lifeact-mApple or Lifeact-EGFP, which provides a biomarker for actin depletion during synapse formation (Ritter et al., 2015).
We imaged the initial steps of activation by expressing tagged PLCγ1, observed in the cytoplasm in CTLs (Figure S1B), rapidly translocating to the plasma membrane of the synapse as F-actin (Lifeact-mApple) depleted across the synapse (Figures 1A–1C; Videos S1A and S1B). PLCγ1, which associates with pLAT upon TCR activation (Braiman et al., 2006, Sommers et al., 2002), is recruited to the plasma membrane both in LAT microclusters and independently of LAT (Sherman et al., 2011). We observed the initial accumulation of PLCγ1 at the synapse 48 s after first contact between CTL and target in the example shown, with small fluorescent puncta visible (Figures 1A and 1B). PLCγ1 accumulation expanded across the area of interaction as the initial depletion of actin was detected (1:36) (min:s) (Figure 1C). PLCγ1 intensity increased across the synapse as it formed and were sustained (∼60 units per pixel) until the peak of actin depletion (3:48), diminishing as actin recovered across the synapse (11:12); small puncta of PLCγ1 then re-appeared as CTLs dissociated from targets.
As PLCγ1 generates diacylglycerol (DAG) by cleavage of PI(4,5)P2, we monitored the production of diacylglycerol (DAG) in the plasma membrane using the EGFP-PKCγ-C1 probe, which detects both the plasma membrane and nuclear pools of DAG. In unstimulated CTLs, only the nuclear pool of DAG was detected (Figure S1C). Upon target cell recognition, DAG accumulates at the synapse at 0:42 after initial contact in the example shown, when actin was enriched across the synapse (Figures 1D–1F; Videos S1A and S1B). DAG accumulation increased as actin depletion began (0:56), distributing across the synapse as actin depleted (2:19) until DAG was no longer detectable by 4:24. The dynamics of PI(4,5)P2 and actin depletion across the synapse followed this same time course, with the depletion of both initially observed 1:20 after initial contact between CTL and target, peaking at 4:40 and recovering simultaneously at 8:27 in the example shown (Figures 2A–2C; Video S2A). Line quantitation of pixel intensity across the synapse demonstrated how the dynamic loss of actin mirrors the loss of PI(4,5)P2 (Figure 2C).
By compiling the data from ≥13 videos for each combination of probes shown, we derived mean timings for these events (Table S1). This analysis revealed that PLCγ1 first appeared at the plasma membrane 1:12 ± 11 s after CTL contact with the target, with DAG detected in the same time frame (58 ± 11 s), and the depletion of PI(4,5)P2 apparent at 1:56 ± 36 s together with the loss of F-actin (1:59 ± 22 s). Co-expression of probes for PLCγ1, DAG, PI(4,5)P2, and PI(3,4,5)P3 confirmed the co-ordinated changes in the phosphoinositides across the synapse with DAG accumulating and PI(4,5)P2 and PI(3,4,5)P3 (discussed below) depleting as PLCγ1 clustered at the synapse (Figures S2A–S2D). These results show that dynamic changes in the phosphoinositide composition of the CTL plasma membrane occur within the first 2 min after cell contact as actin is reorganized across the forming synapse.
The Membrane across the Synapse Undergoes Specialization, with Reduction of PI(4)P, PI(4,5)P2, and PI(3,4,5)P3 and Accumulation of DAG and PI(3,4)P2
The changes in PI(4,5)P2 and DAG seemed likely to affect other plasma membrane phosphoinositides as they lie in the same metabolic pathway (Figure S1A). Therefore, we examined changes in other phosphoinositides before (Figures S1E–S1I) and after synapse formation at the point when actin was depleted (Figures 2D–2F; Videos S2B–S2F). Phosphatidic acid (PA) was evenly distributed across the plasma membrane in CTLs and this distribution did not change upon interaction with target cells, when actin depleted across the synapse. Higher expression at the periphery of the synapse reflected membrane accumulation where CTL actin-rich lamellipodia grasped target cells (see PS images in Figure 2D). Phosphatidylinositol 4-phosphate (PI(4)P) diminished across the synapse as detected using the Osh2p probe (Figures 2D–2F) and was particularly clear when using the P4M probe (Figure S2E; Hammond et al., 2014). In contrast, phosphatidylserine (PS) intensity was maintained at ∼100 units per pixel across the synapse when actin depleted (Figures 2D–2F). Thus, in most instances PA and PS content in the plasma membrane remained unchanged, while PI(4)P decreased together with PI(4,5)P2 as the synapse formed.
We asked whether there was any change in PI(3,4,5)P3 across the synapse in response to PI(4,5)P2 depletion and whether this also affected PI(3,4)P2 and PI(3)P (Figures 2D–2F, S2D, and S2F). Using the Grp1-PH probe, which distinguishes PI(3,4,5)P3 from PI(3,4)P2 (while Akt-PH does not) (Varnai et al., 2017), we confirmed the depletion of PI(3,4,5)P3 across the synapse (Le Floc’h et al., 2013); we were also able to show that this change coincided with depletion of actin across the synapse (Figures 2D–2F). Although the initial binding of the Grp1-PH domain may require interaction with PS in the membrane prior to specific binding to PI(3,4,5)P3 (Lai et al., 2013), our finding that PS remained across the synapse suggests that PS is not playing a role in the differential distribution of Grp1-PH, which thus serves as a true reflection of PI(3,4,5)P3 distribution.
As PI(3,4)P2 is a product of SHIP1 action on PI(3,4,5)P3 (see Figure S1A), we asked whether the depletion of PI(3,4,5)P3 affected PI(3,4)P2 across the synapse using the Bam32 probe (Figure S1A). This revealed that PI(3,4)P2 concentrated at the synapse membrane as actin depleted (Figures 2D–2F), consistent with a role for SHIP1 in the depletion of PI(3,4,5)P3. No changes in PI(3)P were detected at the plasma membrane, with PI(3)P localized on intracellular vesicles both before and after synapse formation (Figure S2F). These vesicles were LAMP1 deficient and did not polarize toward the synapse.
Taken together, these results show that there is a rapid change in membrane composition following the initial hydrolysis of PI(4,5)P2 to DAG by PLCγ1. This results in the formation of an area of membrane that is enriched in DAG and PI(3,4)P2 and depleted in PI(4,5)P2, PI(3,4,5)P3, and PI(4)P, with PA and PS not significantly changed (Figure S2G).
PIP5 Kinase Distribution Changes as the Immune Synapse Forms
The membrane specialization we observed across the immune synapse bore striking similarities to the phosphoinositide composition in primary cilia which, like the immune synapse, are focal centers for signaling, secretion, and endocytosis, with PI(4,5)P2 and PI(3,4,5)P3 depleted across both. This led us to ask whether similar mechanisms controlled membrane composition during both ciliogenesis and immune synapse formation. The phosphatase Inpp5e is required for membrane specialization during ciliogenesis (Chávez et al., 2015, Garcia-Gonzalo et al., 2015, Nakatsu, 2015, Phua et al., 2018). As the balance of PI(4,5)P2 with PI(4)P can be regulated not only by Inpp5e but also the phosphatase OCRL1 and the three isoforms of PIP5K, α, β, and γ (Figure S1A; Hakim et al., 2012, Kwiatkowska, 2010), we asked whether any of these enzymes might play a role in the regulation of PI(4,5)P2 and actin and thereby control secretion from CTLs.
Overexpression of the phosphatases Inpp5e, OCRL1 A, or OCRL1 B with Lifeact-mApple revealed a broad cytoplasmic localization and some co-localization with Arf1, consistent with a concentration of both of these phosphatases on the Golgi apparatus (Figure S3). However, there was little overlap with F-actin localization at the plasma membrane. In contrast, all three PIP5K proteins (α, β, and γ, all of which are expressed in CTLs) not only localized to the plasma membrane but also depleted across the synapse together with F-actin, suggesting a potential role in regulating PI(4,5)P2 across the synapse (Figures 3A–3E; Videos S3A–S3C). We mapped the time course of PIP5Kβ using live imaging. In the example shown, the initial depletion of PIP5Kβ at 2:00 slightly preceded actin depletion at 2:13 when viewed en-face (Figure 3B). The pixel intensity plots show that actin depletion peaked at the same time as PIP5Kβ depletion at 8:26 (Figure 3C). Analyzing videos from 22 independent CTL-target cell conjugates gave mean values of 1:39 ± 10 s for the initiation of PIP5K depletion, with actin depleting almost simultaneously at 1:46 ± 11 s and recovering at 8:30 ± 41 s (Table S1).
PIP5Ks Regulate Actin Recruitment at the Immunological Synapse
Given the coincidence between the depletion of PIP5Ks and actin across the synapse, we asked whether PIP5Ks might play a role in the recruitment of actin to the synapse. We used a plasma membrane localization motif that would retain PIP5Ks across the synapse, by tagging PIP5Kβ-EGFP with the N-terminal Lyn-palmitoylation domain (MGCIKSKRKD) (Inoue et al., 2005). This generated a construct, which we named mPIP5Kβ in which the kinase was active, as well as a kinase-inactive form with a point mutation at K138 (mPIP5Kβ-K138A). Expression of these constructs resulted in plasma membrane localization of PIP5K that persisted at the interface between CTLs and targets (Figures 4A and 4B; Videos S4A and S4C). Strikingly, CTLs expressing mPIP5Kβ were often rounded with only 14% (n = 106) showing any F-actin depletion across the synapse (Figure 4C). In contrast, CTLs expressing the kinase-dead mutation showed a typical polarized morphology with 76% (n = 96) showing depleted actin across the synapse (Figure 4C). These results show that altered localization of PIP5K is sufficient to modulate actin depletion across the synapse and this is dependent on its kinase activity.
Forced Localization of PIP5K to the Synapse Disrupts Centrosome Docking and Secretion
We next asked whether, by controlling changes in the membrane composition across the synapse, PIP5K also played a role in centrosome docking. Fixed CTL-target conjugates were co-stained with phalloidin to detect F-actin and antibodies against acetylated tubulin to identify the centrosome position. Measurement of the distance from the center of the highest concentration of acetylated tubulin to the synapse revealed that centrosome docking was impaired in CTLs expressing mPIP5Kβ, with only 7% docked (8/106) (<0.5 μm); in contrast, CTLs expressing mPIP5Kβ-K138A in which the kinase is inactive showed efficient centrosome docking with 34% (31/92) docking at the synapse (Figures 4D and 4E). Thus, PIP5Ks have an important role in mediating the membrane changes required for efficient centrosome docking at the immune synapse.
We next asked whether granule secretion was impaired by forcing PIP5K to remain across the synapse. CTLs expressing mPIP5Kβ and mPIP5Kβ-K138A formed TCR-activated conjugates in which anti-pY demonstrated phosphorylation at the synapse (Figure S4). We were further able to demonstrate that TCR signals were transduced, as activation gave rise to ERK phosphorylation in both mPIP5Kβ and mPIP5Kβ-K138A, as in CTLs expressing control farnesyl-EGFP (Figure 5A). We next asked whether secretion was impaired using a CD107a (Lamp1) degranulation assay (Figure 5B). In CTLs expressing mPIP5Kβ, there was no shift in CD107a signal upon TCR activation with OVA-pulsed targets compared to mPIP5Kβ-K138A-expressing controls, consistent with a defect in degranulation in CTLs expressing mPIP5Kβ (Figure 5B). We confirmed a loss of CTL cytotoxicity using an assay that measured target cell lysis via loss of a red nuclear marker expressed in target cells (NucRed EL4) (Figure 5C). This showed that while CTLs expressing mPIP5Kβ-K138A or the farnesyl-EGFP membrane marker triggered rapid target cell death, CTLs expressing the kinase active mPIP5Kβ failed to kill target cells. These results indicated that forced localization of PIP5K across the synapse disrupts granule secretion.
PIP5Kα, PIP5Kβ, and PIP5Kγ Are Displaced as Membrane Charge Changes across the Synapse
Given the importance of the redistribution of PIP5Ks across the synapse, we sought to understand the mechanisms controlling membrane localization of PIP5Ks in CTLs. Many different mechanisms have been proposed to regulate PIP5K localization at the plasma membrane based on the ability of PIP5Ks to associate directly with Rac1, ARF6, AP-2, β-arrestin, talin, dishevelled, PA, and PI(4)P (Kwiatkowska, 2010, van den Bout and Divecha, 2009). Studies in macrophages have shown that PIP5K localization can be dictated by membrane charge, with key positively charged amino acids in the activation loop of PIP5K interacting with negatively charged lipid head groups to stabilize PIP5K localization at the membrane (Fairn et al., 2009, Liu et al., 2016).
As the changes in phosphoinositides that we had observed seemed likely to alter membrane charge (cleavage of PI(4,5)P2 to generate DAG removes three negatively charged phosphate groups), we used a Kras+8 probe that binds to negatively charged membranes (Yeung et al., 2008) to detect changes in charge as the synapse forms (Figures 6A–6C; Videos S5A–S5C). Strikingly, the Kras+8 probe associated with the plasma membrane in CTLs but was depleted in concert with actin as the synapse formed, with the pixel intensity plots for Kras8+ and actin closely matching (Figures 6B and 6C; 100% conjugates, n = 15; 8 independent experiments). Analysis of 15 CTLs provided mean times of 1:56 ± 42 s to the initial loss of binding of the charge probe, with actin depletion observed at 2:14 ± 33 s (Table S1).
To ask whether electrostatic interactions between PIP5K and the plasma membrane might be responsible for these changes, we mutated the key charged arginine and lysine residues required for electrostatic membrane association of PIP5K to either alanine (A) or asparagine (N) (Fairn et al., 2009, Liu et al., 2016) and examined the localization at the synapse (Figures 6D and 6E; Videos S5A–S5C). Both sets of mutations resulted in a redistribution of PIP5Kβ from the plasma membrane to the cytoplasm in CTLs (Figure 6E). In contrast, a mutation that destroys kinase activity (K138A) (Ishihara et al., 1998) tested in all three PIP5Ks had no effect on membrane localization (data not shown). These results show that electrostatic charge plays a key role in PIP5K association with the plasma membrane in CTLs and reveals a mechanistic basis for the dissociation of PIP5K as electrostatic charge changes across the synapse.
PIPKs Regulate Membrane Changes across the Synapse
Compiling our data from multiple videos using each of the probes, we were able to determine mean timings for the dynamic changes in membrane composition across the synapse as it formed (Table S1; Figure 7). This revealed how highly co-ordinated these changes were, with DAG accumulation detected very rapidly after PLCγ1 first clusters at the synapse 1 min after CTL contact with the target. We noted that PLCγ1 often appeared initially as small vesicles forming a cluster before merging into a patch. While the resolution of our imaging for these videos cannot resolve the vesicles further, it is possible that this reflects the co-localization of PLCγ1 with LAT, which is vesicle associated (Sherman et al., 2011). While PLCγ1 remained across the synapse for an extended period, disappearing only after 12 min, the probe does not reveal how long the PLCγ1 remained in its active state.
Our results show that PI(4,5)P2 depletion, the decrease in negative charge, dissociation of PIP5Ks, and loss of F-actin across the synapse occur synchronously, initiating ∼2 min after CTL contact with a target and persisting for ∼2 min (Figure 7; Table S1). These results support a model in which PIP5Ks and F-actin are associated with the plasma membrane. Upon TCR activation, PLCγ1 initiates cleavage of PI(4,5)P2 resulting in the appearance of DAG. The depletion of PI(4,5)P2 is accompanied by a loss of negative charge across this area of membrane, triggering dissociation of PIP5Ks from the membrane, preventing the replenishment of PI(4,5)P2. The PI(4,5)P2-dependent recruitment of actin across this membrane is also lost, allowing both centrosome docking and granule secretion to occur (Figure S5). It is important to note that while PLCγ1 initiates the changes at the synapse, our data clearly show that without the dissociation of PIP5Ks, the membrane changes leading to actin depletion do not occur and neither centrosome docking nor secretion can occur. Our data identify PIP5Ks as sensors of TCR signaling, responding to a TCR-induced change in membrane charge and consequently controlling the membrane composition required for secretion in response to TCR signaling.
Discussion
How TCR signaling is sensed and rapidly translated into changes that control granule secretion by CTLs is not understood. Although much is known about the changes in receptor and cytoskeletal organization at the synapse, relatively little is known about the corresponding changes in membrane composition and its importance in controlling centrosome docking and secretion. Recent findings have highlighted the role of PI(4,5)P2 in controlling transient actin depletion across the synapse, but the mechanisms controlling these changes have remained elusive. To investigate changes in membrane composition, we used a panel of bioprobes for phospholipids and their modulating lipases, kinases, and phosphatases to track membrane changes as the synapse forms. Within the first minute after CTL target recognition, PLCγ1 is recruited to the synapse, with the appearance of DAG and loss of PI(4,5)P2 and actin occurring within 2 min of contact. While PA and PI(3)P intensities appeared unchanged, PI(4)P, PI(4,5)P2, and PI(3,4,5)P3 decreased and PI(3,4)P2 increased across the synapse. Thus, a highly specialized domain of the plasma membrane is created rapidly as the synapse forms.
These initial changes in membrane composition result in a loss of negative charge across the CTL membrane, triggering dissociation of electrostatically associated PIP5Ks that otherwise would help to maintain this negative charge by generating PI(4,5)P2 from PI(4)P. This loss of PIP5Ks rapidly amplifies the initial PI(4,5)P2 depletion, driving actin dissociation and allowing granule secretion. We show that membrane association of PIP5Ks is charge dependent, as mutation of conserved positively charged amino acids prevented membrane association. However, by forcing continued PI(4,5)P2 generation across the synapse (using a charge-independent localization motif for PIP5Kβ), actin is maintained across the synapse, blocking centrosome docking and granule secretion upon TCR transduction. A reduced negative charge has also been observed in planar views of the Jurkat immune synapse using FLIM and FRET sensors, suggesting that this mechanism may also be used in CD4 T cells (Ma et al., 2017).
We propose a model in which the initial cleavage of PI(4,5)P2 to DAG by TCR-activated PLCγ triggers the loss of membrane charge that is rapidly amplified by the subsequent loss of PIP5Ks (Figure S5). Other mechanisms may also contribute to changes in membrane charge including DAG phosphorylation by diacylglycerol kinases (DGKs) to generate PA. However, DGKα is confined to the periphery of the synapse, thereby serving to limit DAG to the center of the synapse (Chauveau et al., 2014). It is also possible that changes in PS, the most abundant anionic phospholipid in the membrane, might contribute to the loss of negative charge. Quantitation of PS across the synapse proved difficult with PS-rich intracellular organelles closely associated with the plasma membrane such that no clear change could be detected. During phagocytosis, PIP5Ks are displaced in response to a decrease in surface charge limiting local PI(4,5)P2 generation on the forming phagosome (Fairn et al., 2009, Heo et al., 2006, Liu et al., 2016, Yeung et al., 2009). However, PS is maintained on the forming phagosome by PS delivery from endosomes (Yeung et al., 2009). A similar mechanism for regulating PS may also exist at the synapse, and the contribution of PS to the reduced membrane charge across the synapse remains unclear.
Our study highlights the importance of the dynamic PIP5K localization in controlling membrane changes in response to TCR activation. Previous studies have demonstrated the importance of actin dynamics in controlling granule secretion, with actin shown to deplete prior to granule release (Brown et al., 2011, Hsu et al., 2016, Rak et al., 2011, Ritter et al., 2015, Ritter et al., 2017) and to recover rapidly after degranulation (Brown et al., 2011, Hsu et al., 2016, Rak et al., 2011, Ritter et al., 2015, Ritter et al., 2017). Our studies support a role for PIP5Ks in regulating the actin dynamics controlling secretion from CTLs. Actin dynamics may contribute to CTL killing in other ways and it is tempting to speculate that not only the loss of actin but also the changes in phospholipid content of the membrane itself might cause the changes in membrane tension that facilitate CTL killing described in a previous study (Basu et al., 2016).
Specialized domains of phosphoinositides are also observed during phagocytosis and play important roles in recruiting F-actin during formation and sealing of the phagosomal cup, controlled by modulation of PI(4,5)P2. Changes at the immune synapse appear to be a mirror image of those observed during phagocytosis. However, the specialization seen across the synapse is similar to that recently observed in primary cilia, with both PI(4,5)P2 and PI(3,4,5)P3 lost from the main body of the cilium (Chávez et al., 2015, Dyson et al., 2017, Garcia-Gonzalo et al., 2015). As both centrosome docking at the synapse and ciliogenesis are disrupted when membrane composition is perturbed, this raises the possibility that membrane specialization might be required for successful centrosome docking in both contexts.
In conclusion, here we show how TCR signaling rapidly creates an area of plasma membrane specialization with a unique phosphoinositide composition and a reduced negative charge across the immune synapse, causing PIP5Ks to dissociate from the plasma membrane. Thus, PI(4,5)P2 depletion initiated upon TCR activation is perpetuated by the loss of PIP5Ks. The loss of PI(4,5)P2 and the consequent loss of F-actin polymerization facilitates centrosome docking and granule secretion in exact synchrony with TCR signaling, with PIP5Ks acting as sensors of TCR signaling, modifying the plasma membrane to facilitate granule secretion.
STAR★Methods
Key Resources Table
REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Antibodies | ||
Mouse monoclonal anti-acetylated tubulin | Sigma-Aldrich | Cat # T7451; RRID: AB_609894 |
Mouse Anti-Phosphotyrosine Platinum 4G10 | Merck/Millipore | Cat# 05-1050X; RRID:AB_916370 |
Alexa Fluor 647 donkey anti-mouse (H+L) | Thermo Fisher scientific | Cat# A-31571; RRID:AB_162542 |
Alexa Fluor 405 goat anti-rabbit IgG (H+L) | Thermo Fisher scientific | Cat# A-31556; RRID:AB_221605 |
Rat anti-CD107a PE | Thermo Fisher scientific | Cat# 12-1071-82; RRID:AB_657556 |
Rat anti CD16/CD32 (FcR blocking antibody) | Biolegend | Cat# 101301; RRID:AB_312800 |
Rat anti-CD8 Brilliant Violet 711 | Biolegend | Cat# 100747; RRID:AB_11219594 |
Hamster Anti-mouse CD3ε | BD Bioscience | Cat# 550275; RRID:AB_393572 |
Rabbit anti-pErk1/2(T202/Y204) D13.14.4E | Cell Signaling Technology | Cat# 4370; RRID:AB_2315112 |
Rabbit mAb IgG Isotype Control DA1E | Cell Signaling technology | Cat# 3900; RRID:AB_1550038 |
Bacterial and Virus Strains | ||
NEB 10-beta Competent E. coli DH10B | New England BioLabs | C3019 |
Chemicals, Peptides, and Recombinant Proteins | ||
SIINFEKL (Ovalbumin peptide 257-264) | Anaspec | AS-60193-1 |
ASNENMDAM (NP68 peptide 366-374) | Anaspec | AS-60623 |
Recombinant mouse ICAM-1/CD45 Fc Chimera Protein | R&D Systems | 796-IC |
Alexa Fluor 555-Phalloidin | Invitrogen | A34055 |
4’,6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI) | Invitrogen | D1306 |
16% w/v paraformaldehyde | Electron Microscopy Sciences | 15710 s |
Bovine serum albumin (heat shock fractionation pH 7) | Sigma Aldrich | A7906 |
Prolong Diamond mounting medium | Invitrogen | P36962 |
Puromycin | GIBCO/Thermo Fisher | A1113803 |
Murine Interleukin 2 (IL-2) | Peprotech | 212-12 |
L-Glutamine 200 mM | GIBCO | 25030-024 |
Fetal bovine serum (FBS), heat inactivated | Labtech | FCS-SA |
Penicillin/Streptomycin (P/S) | Sigma-Aldrich | P0781 |
DMEM (+ L-glutamine) | GIBCO | 41966029 |
CO2 independent medium (-L-Glutamine) | GIBCO | 18045-054 |
BamHI | Fermentas/Thermo Fisher | FD0054 |
BshTI | Fermentas/Thermo Fisher | FD1464 |
Eco91I | Fermentas/Thermo Fisher | FD0394 |
HindIII | Fermentas/Thermo Fisher | FD0504 |
KpnI | Fermentas/Thermo Fisher | FD0524 |
NheI | Fermentas/Thermo Fisher | FD0973 |
SalI | Fermentas/Thermo Fisher | FD0644 |
XhoI | Fermentas/Thermo Fisher | FD0694 |
BsrGI | New England Biolabs | R0575 |
KpnI | New England Biolabs | R0142 |
Experimental Models: Cell Lines | ||
EL4-Farnesyl-5-TagBFP2 (EL4-blue) | (Ritter et al., 2015) | N/A |
EL4-NucLight-Red | This paper | N/A |
EL4-MEM-iRFP670 (FR-EL4) | This paper | N/A |
EL4 ATCC TIB39 | ATCC | ATCC Cat# TIB-39; RRID:CVCL_0255 |
Experimental Models: Organisms/Strains | ||
B6.SVJ129-RAG1TM1BAL TG(TCRATCRB)1100MJB | JAX | Cat# JAX:003831, RRID:IMSR_JAX:003831 |
Recombinant DNA | ||
EGFP-Lactadherin-C2 | S. Grinstein | (Yeung et al., 2008) |
EGFP-Kras+8 | S. Grinstein | (Yeung et al., 2008) |
EGFP-Grp1-PH | C. Watts | (Kimber et al., 2002) |
EGFP-FYVEx2 | H. Stenmark | (Gillooly et al., 2000) |
EGFP-OCRL1A/B | M.Lowe | (Choudhury et al., 2005) |
mApple-Lifeact-7 | Addgene | 54747; RRID:SCR_002037 |
mEGFP-Lifeact-7 | Addgene | 54610; RRID:SCR_002037 |
mCherry-PIP5Kγ661 | Addgene | 29584; RRID:SCR_002037 |
EGFP-P4M-SidMx2 | Addgene | 51472; RRID:SCR_002037 |
EGFP-Osh2p-PHx2 | T.Balla | (Szentpetery et al., 2009) |
EGFP-Tubby | T.Balla | (Szentpetery et al., 2009) |
mTagRFP-N | Evrogen | FP142 |
EGFP-C1, N1 and mCherry-C1 | Takara Bio/Clontech | 6084-1, 6085-1 & 632524 |
mPIP5K1β-EGFP | This paper | GeneBank: P25911/P70181 |
mPIP5K-K138A-EGFP | This paper | GeneBank: P25911/P70181 |
EGFP-NES-PASS | This Paper | GeneBank: P63248/Q04359 |
EGFP-NES-Bam32-PH | This paper | GeneBank: P63248/Q9QXT1 |
EGFP-PKCγ-C1 domain | This paper | GeneBank: P63318 |
EGFP-PIP5Kα | This paper | GeneBank: P70182 |
PIP5Kβ-EGFP | This paper | GeneBank: P70181 |
PIP5Kβ-KR_A-EGFP | This paper | GeneBank: P25911/P70181 |
PIP5Kβ-KR_N-EGFP | This paper | GeneBank: P25911/P70181 |
EGFP-Inpp5e | This paper | GeneBank: Q9JII1 |
PLCγ1-EGFP | This paper | GeneBank: Q62077 |
PKAi-NES-PASS gBlock | This paper | Integrated DNA Technologies |
PKAi-NES-Bam32-PH gBlock | This paper | Integrated DNA Technologies |
PKCγ-C1 domain gBlock | This paper | Integrated DNA Technologies |
PIP5Kβ K_RA gBlock | This paper | Integrated DNA Technologies |
PIP5KβK_RN gBlock | This paper | Integrated DNA Technologies |
Software and Algorithms | ||
Imaris | Bitplane | RRID:SCR_007370 |
Prism 5 | Graphpad | RRID:SCR_002798 |
IncuCyte Spheroid Software Module | Essen BioScience, Sartorius | 9600-0019 |
FlowJo software v10 and v9 | Flow Jo LLC treestar | RRID:SCR_008520 |
ImageJ | ImageJ.net | RRID:SCR_003070 |
Contact for Reagent and Resource Sharing
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Professor Gillian M Griffiths (gg305@cam.ac.uk).
Experimental Model and Subject Details
C57BL/6 OT-IRag1−/− mice (RRID:IMSR_JAX:003831) This research has been regulated under the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 following ethical review by the University of Cambridge Animal Welfare and Ethical Review Body (AWERB).
Method Details
Tissue culture and cell preparation
Splenocytes from C57BL/6 OT-IRag1−/− mice (RRID:IMSR_JAX:003831) were isolated by manual rupture of the spleen. Splenocytes were resuspended (∼108 cells/mL) in culture media (RPMI, 10% FCS, 50 U/mL penicillin-streptomycin, 1 mM sodium pyruvate, 2mM L-glutamine, 50μM β2-mercaptoethanol, 100 U/mL IL-2) and incubated with 10 nM SIINFEKL peptide for 3 days at 37°C, 8% CO2, washed and cultured for a total of 5-10 days. EL4-MEM-iRFP670 were generated by transduction of EL4 with pMig-MEM-RFP670,. EL4-Farnesyl-5-TagBFP2 (EL4-blue) and EL4-MEM-iRFP670 (FR-EL4) target cells were maintained in DMEM, 2mM L-glutamine, 10% FBS (GIBCO), 50 U/mL pen/strep (EL4 media).
RNA preparation, cDNA generation cloning and plasmids
cDNA was synthesized using oligo dT primers from RNA isolated from 5x106 OT-I CTL (3-5 days post-activation) with the RNA mini (QIAGEN) and AffinityScript cDNA synthesis kits (Agilent technologies). PCR amplifications were carried out using AccuPrime Pfx DNA polymerase kits in a G-storm thermal cycler system 482 (G-storm Ltd, Labtech International). Site-directed mutagenesis used the QuickChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies); ligations, the Quick ligation kit (New England Biolabs). Synthesized double stranded DNA were designed then manufactured by Integrated DNA Technologies (gBlocks; IDT, Iowa, USA) and cloned into pSC-B carrier plasmids using the StrataClone Blunt PCR Cloning Kit (Agilent Technologies).
Lipid probes
EGFP-Tubby was used to detect PI(4,5)P2. The C1-domains of PKCγ equivalent to amino acids (aa) 35-150 were made into a gBlock and cloned into EGFP-C1 (Clontech) at KpnI and BamHI sites to detect DAG. Likewise, a gBlock corresponding to the phosphatidic acid biosensor with superior sensitivity (PASS), derived from the yeast protein Spo20p phosphatidic acid binding domain (PABD) (Zhang et al., 2014) was also cloned into EGFP-C1 at restriction sites XhoI and SalI. Detection of PI(4)P was with Osh2p (Roy and Levine, 2004). PS was detected with the C2 domain of Lactadherin (Yeung et al., 2008). Detection of PI(3,4,5)P3 used the specific Grp1-PH probe (Kavran et al., 1998). As both Bam32-PH and the TAPP1-PH domains available to detect PI(3,4)P2 showed strong nuclear localization (Anderson et al., 2000, Kimber et al., 2002), we included the nuclear export signal (NES) of Protein Kinase A inhibitor aa 38-47 (LALKLAGLDI) before the Bam32-PH domain aa 164-256. NES-Bam32 was made into a gBlock and inserted into EGFP-C1 at restriction sites BsrGI and KpnI. This improved signal for the plasma membrane pool of PI(3,4)P2. PI(3)P was detected using EGFP-FYVEx2 (Gillooly et al., 2000).
Cell preparation for live cell microscopy
1 × 107 OT-I CTLs (5–8 days after activation) were nucleofected 24 h prior to imaging with 5 μg Lifeact-mApple and probe construct plasmids using the Mouse T Cell Nucleofector Kit (Lonza). EL4-blue target cells were pulsed with 1 μM SIINFEKL for 30 min at 37°C, washed in serum-free CO2-independent medium (with L-glutamine) and plated onto 35-mm glass-bottom culture dishes (MatTek) coated with 0.5 μg/mL murine ICAM-1/Fc. ∼2 × 106 nucleofected CTLs in CO2-independent T cell medium were added dropwise, imaging was started within 5 min. Interactions were imaged with cells in an environmental chamber maintained at 37°C (Okolabs) on an Olympus IX81 microscope (Olympus) using the Andor Revolution spinning-disc microscope with Yokogawa CSU-X1 spinning disk, iXon Ultra 888 EMCCD camera, 2x camera adaptor (Andor Technology, Oxford instruments) and Olympus Universal Plan Super Apochromat silicone immersion objective. 12-18 z stacks (0.8-μm apart) were imaged every 12 s with fluorophores excited at 405, 488, and 561 nm in each z-plane. 4D datasets were rendered and analyzed with Imaris software (Bitplane).
Fixed cell preparation, image collection and quantitation
OT-I CTLs (2-6 days post-activation) were nucleofected with 5 μg DNA encoding wild-type mPIP5Kβ or mPIP5Kβ-K138A, mixed with peptide pulsed targets (as above) in serum-free, CO2-independent T cell media at 37°C for 5 min, plated onto glass coverslips (n = 1.5; VWR) and allowed to form conjugates for 20 min. Cells were fixed with 4% v/v paraformaldehyde at 37°C and washed at room temperature with PBS and quenched in Tris buffered saline (TBS) before permeabilization in TBS, 0.2% Triton X-100 (Sigma Aldrich) for 5 min. Samples were blocked with TBS, 2% BSA for 20 min before incubation with mouse anti-acetyl tubulin for 1h. Samples were washed in tris buffered saline and incubated with goat anti-mouse IgG-Alexa 647 and Phalloidin-Alexa fluor 555 for 30 min. Coverslips were washed, mounted with Prolong Diamond mounting medium and imaged on an Andor Revolution spinning-disc microscope (as above) with z stacks at 0.15 μm intervals.
Intracellular Phospho-protein Flow Cytometry
Nucleofected cells were sorted for GFP expression, and stimulated with 2 μg/mL plate-bound anti-CD3ε antibody for 60 min at 37°C. Cells were fixed in 4% paraformaldehyde at room temperature for 15 min and washed in PBS. Pre-chilled cells were permeabilized with 90% ice-cold methanol for 30 min on ice. Cells were washed in PBS and resuspended in buffer (1% FBS in PBS) with 1 μg/mL FcR blocking antibody with either 2.5 μg/mL rabbit anti-pERK1/2 antibody or 12.5 μg/mL rabbit IgG isotype control antibody and incubated for 1h at room temperature. After washing in buffer, cells were resuspended in buffer containing 1 μg/mL FcR antibody and 10 μg/mL Alexa Fluor 405 goat-anti-rabbit incubated for 30 min at room temperature. Cells were washed in incubation buffer prior to data acquisition on a BD LSRFortessa (BD Biosciences). The data was analyzed with FlowJo (FlowJo, LLC).
Degranulation assay
FR-EL4-were pulsed with 1 μM ovalbumin peptide (SIINFEKL) or control peptide NP68 (ASNENMDAM) for 1 hour at 37°C before washing to remove free peptide. 1x105 CTLs were cultured 1:1 with pulsed FR-EL4 cells for 2.5 h in culture media supplemented with 2 μg/mL anti-CD107a PE in round-bottom 96-well plates. Cells were stained on ice with FCR antibody, DAPI, and anti-CD8 Brilliant Violet 711. Flow cytometry was performed on BD LSRFortessa (BD Biosciences) and data were analyzed in FlowJo.
Cytotoxicity assay
EL4 cells expressing a non-perturbing red nuclear marker (NucLight-Red; Essen Bioscience, Sartorius) (NucRed EL4) were pulsed with 1 mM SIINFEKL peptide, washed and incubated with OT-I CTL expressing either mPIP5Kβ-EGFP or mPIP5Kβ-K138A-EGFP or farnesyl-EGFP. Triplicate samples of 20000 CTL were plated with 2000 EL4 cells per well. The assay was performed in an IncuCyte S3 live cell analysis system (Essen Bioscience, Sartorius) maintained at 37°C and 10% CO2. Cells were allowed to settle in the plates for 30 min and images were captured every 30 min over 4 h using the 565-605nm laser line and the 4x objective. Loss of NucRed EL4 intensity was quantitated using IncuCyte S3 software with the spheroid quantitation application. Data were exported and calculated as percentage of target cell loss based on the initial target cell number for each well analyzed then plotted using Prism software (Graphpad).
Quantification and Statistical Analysis
Cell choice
Nucleofected OT-I cells were added dropwise to dishes and allowed to settle for less than 5 min. After this point a systematic scan across the dish was undertaken until a cell that was double labeled (expressing both nucleofected plasmids) to detectable level and in close location to the target EL4 blue was selected for filming. In fixed samples a systematic scan was made from the top left of the coverslip to the right and images were taken at either 60 or 100x of the EGFP positive cells for quantitation measurements. Images were analyzed using Imaris software (Bitplane) line tool to determine centrosome-to-synapse distances and > 5-fold depletion of the F-actin signal across the synapse relative to membrane outside the synapse.
Quantitation in ImageJ/Fiji
Movies of CTL expressing lipid probes and Lifeact during synapse formation were analyzed using Imaris software. Single representative Z-planes within the projected images through the center of the synapse were captured as Tiff files, opened in ImageJ/Fiji (ImageJ open source software http://Imagej.net) and split into their respective red, green and blue channels. Pixel intensity values were determined across 2.1 μm depth as indicated in each figure to capture the undulating interface across each synapse. “Accumulation” is defined as pixel intensity > pixel intensity at initial contact (t = 0); “peak” intensity as the highest pixel intensity value compared to t = 0 and “recovered” when pixel intensity values return to t = 0. Fold changes vary for different probes as shown in pixel intensity plots for each figure.
Error
All error in graphs is standard error of the mean or propagated standard error of the mean where it is stated (Figure 5C)
Data and Software Availability
Due to the size of the raw dataset it will be made available on request.
Acknowledgments
Research was funded by Wellcome Trust grants 103930 and 100140 to G.M.G., an MRC Skills Development Fellowship to A.C.R. (P014178), and an Addenbrooke's Charitable Trust Clinical Research Fellowship to C.Y.M. (23/17). We thank Yukako Asano for generating the EL4-FR cell line and Figure S5; Sergio Grinstein for helpful discussions; Reiner Schulte and Chiara Cossetti from the cell cytometry facility; and Jane Stinchcombe, Yukako Asano, and Alison Schuldt for critical reading of the manuscript.
Author Contributions
G.M.G. and C.M.G.-B. designed the study and wrote the paper. C.M.G.-B. generated all data and analysis in Figure 1, Figure 2, Figure 3, Figure 4, 6, 7, and S1–S4; C.Y.M., Figure 5A; A.C.R., Figures 5B and S5; G.L.F. and K.S., Figure 5C.
Declaration of Interests
The authors declare no competing interests.
Published: September 11, 2018
Footnotes
Supplemental Information includes five figures, one table, and five videos and can be found with this article online at https://doi.org/10.1016/j.immuni.2018.08.017.
Supplemental Information
References
- Anderson K.E., Lipp P., Bootman M., Ridley S.H., Coadwell J., Rönnstrand L., Lennartsson J., Holmes A.B., Painter G.F., Thuring J. DAPP1 undergoes a PI 3-kinase-dependent cycle of plasma-membrane recruitment and endocytosis upon cell stimulation. Curr. Biol. 2000;10:1403–1412. doi: 10.1016/s0960-9822(00)00794-6. [DOI] [PubMed] [Google Scholar]
- Balla T. Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol. Rev. 2013;93:1019–1137. doi: 10.1152/physrev.00028.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Basu R., Whitlock B.M., Husson J., Le Floc’h A., Jin W., Oyler-Yaniv A., Dotiwala F., Giannone G., Hivroz C., Biais N. Cytotoxic T cells use mechanical force to potentiate target cell killing. Cell. 2016;165:100–110. doi: 10.1016/j.cell.2016.01.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Braiman A., Barda-Saad M., Sommers C.L., Samelson L.E. Recruitment and activation of PLCgamma1 in T cells: a new insight into old domains. EMBO J. 2006;25:774–784. doi: 10.1038/sj.emboj.7600978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown A.C., Oddos S., Dobbie I.M., Alakoskela J.M., Parton R.M., Eissmann P., Neil M.A., Dunsby C., French P.M., Davis I., Davis D.M. Remodelling of cortical actin where lytic granules dock at natural killer cell immune synapses revealed by super-resolution microscopy. PLoS Biol. 2011;9:e1001152. doi: 10.1371/journal.pbio.1001152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carisey A.F., Mace E.M., Saeed M.B., Davis D.M., Orange J.S. Nanoscale dynamism of actin enables secretory function in cytolytic cells. Curr. Biol. 2018;28:489–502.e9. doi: 10.1016/j.cub.2017.12.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chauveau A., Le Floc’h A., Bantilan N.S., Koretzky G.A., Huse M. Diacylglycerol kinase α establishes T cell polarity by shaping diacylglycerol accumulation at the immunological synapse. Sci. Signal. 2014;7:ra82. doi: 10.1126/scisignal.2005287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chávez M., Ena S., Van Sande J., de Kerchove d’Exaerde A., Schurmans S., Schiffmann S.N. Modulation of ciliary phosphoinositide content regulates trafficking and sonic hedgehog signaling output. Dev. Cell. 2015;34:338–350. doi: 10.1016/j.devcel.2015.06.016. [DOI] [PubMed] [Google Scholar]
- Choudhury R., Diao A., Zhang F., Eisenberg E., Saint-Pol A., Williams C., Konstantakopoulos A., Lucocq J., Johannes L., Rabouille C. Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network. Mol. Biol. Cell. 2005;16:3467–3479. doi: 10.1091/mbc.E05-02-0120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Di Paolo G., De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature. 2006;443:651–657. doi: 10.1038/nature05185. [DOI] [PubMed] [Google Scholar]
- Dyson J.M., Conduit S.E., Feeney S.J., Hakim S., DiTommaso T., Fulcher A.J., Sriratana A., Ramm G., Horan K.A., Gurung R. INPP5E regulates phosphoinositide-dependent cilia transition zone function. J. Cell Biol. 2017;216:247–263. doi: 10.1083/jcb.201511055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fairn G.D., Ogata K., Botelho R.J., Stahl P.D., Anderson R.A., De Camilli P., Meyer T., Wodak S., Grinstein S. An electrostatic switch displaces phosphatidylinositol phosphate kinases from the membrane during phagocytosis. J. Cell Biol. 2009;187:701–714. doi: 10.1083/jcb.200909025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garcia-Gonzalo F.R., Phua S.C., Roberson E.C., Garcia G., 3rd, Abedin M., Schurmans S., Inoue T., Reiter J.F. Phosphoinositides regulate ciliary protein trafficking to modulate hedgehog signaling. Dev. Cell. 2015;34:400–409. doi: 10.1016/j.devcel.2015.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gillooly D.J., Morrow I.C., Lindsay M., Gould R., Bryant N.J., Gaullier J.M., Parton R.G., Stenmark H. Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J. 2000;19:4577–4588. doi: 10.1093/emboj/19.17.4577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hakim S., Bertucci M.C., Conduit S.E., Vuong D.L., Mitchell C.A. Inositol polyphosphate phosphatases in human disease. Curr. Top. Microbiol. Immunol. 2012;362:247–314. doi: 10.1007/978-94-007-5025-8_12. [DOI] [PubMed] [Google Scholar]
- Hammond G.R., Machner M.P., Balla T. A novel probe for phosphatidylinositol 4-phosphate reveals multiple pools beyond the Golgi. J. Cell Biol. 2014;205:113–126. doi: 10.1083/jcb.201312072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heo W.D., Inoue T., Park W.S., Kim M.L., Park B.O., Wandless T.J., Meyer T. PI(3,4,5)P3 and PI(4,5)P2 lipids target proteins with polybasic clusters to the plasma membrane. Science. 2006;314:1458–1461. doi: 10.1126/science.1134389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hsu H.T., Mace E.M., Carisey A.F., Viswanath D.I., Christakou A.E., Wiklund M., Önfelt B., Orange J.S. NK cells converge lytic granules to promote cytotoxicity and prevent bystander killing. J. Cell Biol. 2016;215:875–889. doi: 10.1083/jcb.201604136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Inoue T., Heo W.D., Grimley J.S., Wandless T.J., Meyer T. An inducible translocation strategy to rapidly activate and inhibit small GTPase signaling pathways. Nat. Methods. 2005;2:415–418. doi: 10.1038/nmeth763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ishihara H., Shibasaki Y., Kizuki N., Wada T., Yazaki Y., Asano T., Oka Y. Type I phosphatidylinositol-4-phosphate 5-kinases. Cloning of the third isoform and deletion/substitution analysis of members of this novel lipid kinase family. J. Biol. Chem. 1998;273:8741–8748. doi: 10.1074/jbc.273.15.8741. [DOI] [PubMed] [Google Scholar]
- Janmey P.A., Lindberg U. Cytoskeletal regulation: rich in lipids. Nat. Rev. Mol. Cell Biol. 2004;5:658–666. doi: 10.1038/nrm1434. [DOI] [PubMed] [Google Scholar]
- Jenkins M.R., Stinchcombe J.C., Au-Yeung B.B., Asano Y., Ritter A.T., Weiss A., Griffiths G.M. Distinct structural and catalytic roles for Zap70 in formation of the immunological synapse in CTL. eLife. 2014;3:e01310. doi: 10.7554/eLife.01310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kalina M., Berke G. Contact regions of cytotoxic T lymphocyte-target cell conjugates. Cell. Immunol. 1976;25:41–51. doi: 10.1016/0008-8749(76)90095-2. [DOI] [PubMed] [Google Scholar]
- Kavran J.M., Klein D.E., Lee A., Falasca M., Isakoff S.J., Skolnik E.Y., Lemmon M.A. Specificity and promiscuity in phosphoinositide binding by pleckstrin homology domains. J. Biol. Chem. 1998;273:30497–30508. doi: 10.1074/jbc.273.46.30497. [DOI] [PubMed] [Google Scholar]
- Kimber W.A., Trinkle-Mulcahy L., Cheung P.C., Deak M., Marsden L.J., Kieloch A., Watt S., Javier R.T., Gray A., Downes C.P. Evidence that the tandem-pleckstrin-homology-domain-containing protein TAPP1 interacts with Ptd(3,4)P2 and the multi-PDZ-domain-containing protein MUPP1 in vivo. Biochem. J. 2002;361:525–536. doi: 10.1042/0264-6021:3610525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kolay S., Basu U., Raghu P. Control of diverse subcellular processes by a single multi-functional lipid phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] Biochem. J. 2016;473:1681–1692. doi: 10.1042/BCJ20160069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kwiatkowska K. One lipid, multiple functions: how various pools of PI(4,5)P(2) are created in the plasma membrane. Cell. Mol. Life Sci. 2010;67:3927–3946. doi: 10.1007/s00018-010-0432-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lai C.L., Srivastava A., Pilling C., Chase A.R., Falke J.J., Voth G.A. Molecular mechanism of membrane binding of the GRP1 PH domain. J. Mol. Biol. 2013;425:3073–3090. doi: 10.1016/j.jmb.2013.05.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Le Floc’h A., Tanaka Y., Bantilan N.S., Voisinne G., Altan-Bonnet G., Fukui Y., Huse M. Annular PIP3 accumulation controls actin architecture and modulates cytotoxicity at the immunological synapse. J. Exp. Med. 2013;210:2721–2737. doi: 10.1084/jem.20131324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lemmon M.A. Membrane recognition by phospholipid-binding domains. Nat. Rev. Mol. Cell Biol. 2008;9:99–111. doi: 10.1038/nrm2328. [DOI] [PubMed] [Google Scholar]
- Liu A., Sui D., Wu D., Hu J. The activation loop of PIP5K functions as a membrane sensor essential for lipid substrate processing. Sci. Adv. 2016;2:e1600925. doi: 10.1126/sciadv.1600925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ma Y., Yamamoto Y., Nicovich P.R., Goyette J., Rossy J., Gooding J.J., Gaus K. A FRET sensor enables quantitative measurements of membrane charges in live cells. Nat. Biotechnol. 2017;35:363–370. doi: 10.1038/nbt.3828. [DOI] [PubMed] [Google Scholar]
- Nakatsu F. A phosphoinositide code for primary cilia. Dev. Cell. 2015;34:379–380. doi: 10.1016/j.devcel.2015.08.008. [DOI] [PubMed] [Google Scholar]
- Ooms L.M., Horan K.A., Rahman P., Seaton G., Gurung R., Kethesparan D.S., Mitchell C.A. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem. J. 2009;419:29–49. doi: 10.1042/BJ20081673. [DOI] [PubMed] [Google Scholar]
- Phua S.C., Nihongaki Y., Inoue T. Autonomy declared by primary cilia through compartmentalization of membrane phosphoinositides. Curr. Opin. Cell Biol. 2018;50:72–78. doi: 10.1016/j.ceb.2018.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pirruccello M., De Camilli P. Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL. Trends Biochem. Sci. 2012;37:134–143. doi: 10.1016/j.tibs.2012.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pollard T.D., Borisy G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell. 2003;112:453–465. doi: 10.1016/s0092-8674(03)00120-x. [DOI] [PubMed] [Google Scholar]
- Quann E.J., Merino E., Furuta T., Huse M. Localized diacylglycerol drives the polarization of the microtubule-organizing center in T cells. Nat. Immunol. 2009;10:627–635. doi: 10.1038/ni.1734. [DOI] [PubMed] [Google Scholar]
- Rak G.D., Mace E.M., Banerjee P.P., Svitkina T., Orange J.S. Natural killer cell lytic granule secretion occurs through a pervasive actin network at the immune synapse. PLoS Biol. 2011;9:e1001151. doi: 10.1371/journal.pbio.1001151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raucher D., Stauffer T., Chen W., Shen K., Guo S., York J.D., Sheetz M.P., Meyer T. Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion. Cell. 2000;100:221–228. doi: 10.1016/s0092-8674(00)81560-3. [DOI] [PubMed] [Google Scholar]
- Ritter A.T., Asano Y., Stinchcombe J.C., Dieckmann N.M., Chen B.C., Gawden-Bone C., van Engelenburg S., Legant W., Gao L., Davidson M.W. Actin depletion initiates events leading to granule secretion at the immunological synapse. Immunity. 2015;42:864–876. doi: 10.1016/j.immuni.2015.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ritter A.T., Kapnick S.M., Murugesan S., Schwartzberg P.L., Griffiths G.M., Lippincott-Schwartz J. Cortical actin recovery at the immunological synapse leads to termination of lytic granule secretion in cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 2017;114:E6585–E6594. doi: 10.1073/pnas.1710751114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rohatgi R., Ho H.Y., Kirschner M.W. Mechanism of N-WASP activation by CDC42 and phosphatidylinositol 4, 5-bisphosphate. J. Cell Biol. 2000;150:1299–1310. doi: 10.1083/jcb.150.6.1299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ross S.H., Rollings C., Anderson K.E., Hawkins P.T., Stephens L.R., Cantrell D.A. Phosphoproteomic analyses of interleukin 2 signaling reveal integrated JAK kinase-dependent and -independent networks in CD8(+) T cells. Immunity. 2016;45:685–700. doi: 10.1016/j.immuni.2016.07.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roy A., Levine T.P. Multiple pools of phosphatidylinositol 4-phosphate detected using the pleckstrin homology domain of Osh2p. J. Biol. Chem. 2004;279:44683–44689. doi: 10.1074/jbc.M401583200. [DOI] [PubMed] [Google Scholar]
- Sanderson C.J. The mechanism of T cell mediated cytotoxicity. I. The release of different cell components. Proc. R. Soc. Lond. B Biol. Sci. 1976;192:221–239. doi: 10.1098/rspb.1976.0010. [DOI] [PubMed] [Google Scholar]
- Sanderson C.J., Glauert A.M. The mechanism of T cell mediated cytotoxicity. V. Morphological studies by electron microscopy. Proc. R. Soc. Lond. B Biol. Sci. 1977;198:315–323. doi: 10.1098/rspb.1977.0100. [DOI] [PubMed] [Google Scholar]
- Sanderson C.J., Glauert A.M. The mechanism of T-cell mediated cytotoxicity. VI. T-cell projections and their role in target cell killing. Immunology. 1979;36:119–129. [PMC free article] [PubMed] [Google Scholar]
- Sherman E., Barr V., Manley S., Patterson G., Balagopalan L., Akpan I., Regan C.K., Merrill R.K., Sommers C.L., Lippincott-Schwartz J., Samelson L.E. Functional nanoscale organization of signaling molecules downstream of the T cell antigen receptor. Immunity. 2011;35:705–720. doi: 10.1016/j.immuni.2011.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sommers C.L., Park C.S., Lee J., Feng C., Fuller C.L., Grinberg A., Hildebrand J.A., Lacaná E., Menon R.K., Shores E.W. A LAT mutation that inhibits T cell development yet induces lymphoproliferation. Science. 2002;296:2040–2043. doi: 10.1126/science.1069066. [DOI] [PubMed] [Google Scholar]
- Spitaler M., Emslie E., Wood C.D., Cantrell D. Diacylglycerol and protein kinase D localization during T lymphocyte activation. Immunity. 2006;24:535–546. doi: 10.1016/j.immuni.2006.02.013. [DOI] [PubMed] [Google Scholar]
- Stinchcombe J.C., Griffiths G.M. Secretory mechanisms in cell-mediated cytotoxicity. Annu. Rev. Cell Dev. Biol. 2007;23:495–517. doi: 10.1146/annurev.cellbio.23.090506.123521. [DOI] [PubMed] [Google Scholar]
- Stinchcombe J.C., Majorovits E., Bossi G., Fuller S., Griffiths G.M. Centrosome polarization delivers secretory granules to the immunological synapse. Nature. 2006;443:462–465. doi: 10.1038/nature05071. [DOI] [PubMed] [Google Scholar]
- Stinchcombe J.C., Randzavola L.O., Angus K.L., Mantell J.M., Verkade P., Griffiths G.M. Mother centriole distal appendages mediate centrosome docking at the immunological synapse and reveal mechanistic parallels with ciliogenesis. Curr. Biol. 2015;25:3239–3244. doi: 10.1016/j.cub.2015.10.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Szentpetery Z., Balla A., Kim Y.J., Lemmon M.A., Balla T. Live cell imaging with protein domains capable of recognizing phosphatidylinositol 4,5-bisphosphate; a comparative study. BMC Cell Biol. 2009;10:67. doi: 10.1186/1471-2121-10-67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tanos B.E., Yang H.J., Soni R., Wang W.J., Macaluso F.P., Asara J.M., Tsou M.F. Centriole distal appendages promote membrane docking, leading to cilia initiation. Genes Dev. 2013;27:163–168. doi: 10.1101/gad.207043.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Trimble W.S., Grinstein S. Barriers to the free diffusion of proteins and lipids in the plasma membrane. J. Cell Biol. 2015;208:259–271. doi: 10.1083/jcb.201410071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van den Bout I., Divecha N. PIP5K-driven PtdIns(4,5)P2 synthesis: regulation and cellular functions. J. Cell Sci. 2009;122:3837–3850. doi: 10.1242/jcs.056127. [DOI] [PubMed] [Google Scholar]
- Varnai P., Gulyas G., Toth D.J., Sohn M., Sengupta N., Balla T. Quantifying lipid changes in various membrane compartments using lipid binding protein domains. Cell Calcium. 2017;64:72–82. doi: 10.1016/j.ceca.2016.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yeung T., Gilbert G.E., Shi J., Silvius J., Kapus A., Grinstein S. Membrane phosphatidylserine regulates surface charge and protein localization. Science. 2008;319:210–213. doi: 10.1126/science.1152066. [DOI] [PubMed] [Google Scholar]
- Yeung T., Heit B., Dubuisson J.F., Fairn G.D., Chiu B., Inman R., Kapus A., Swanson M., Grinstein S. Contribution of phosphatidylserine to membrane surface charge and protein targeting during phagosome maturation. J. Cell Biol. 2009;185:917–928. doi: 10.1083/jcb.200903020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang F., Wang Z., Lu M., Yonekubo Y., Liang X., Zhang Y., Wu P., Zhou Y., Grinstein S., Hancock J.F., Du G. Temporal production of the signaling lipid phosphatidic acid by phospholipase D2 determines the output of extracellular signal-regulated kinase signaling in cancer cells. Mol. Cell. Biol. 2014;34:84–95. doi: 10.1128/MCB.00987-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.